Recursion Pharmaceuticals-a Forecast and Target Price
$6.47
Recursion Pharmaceuticals-a (RXRX) Share Price Forecast
Currently 13 wall-street analysts regularly analyze the financials of Recursion Pharmaceuticals-a on a frequent basis to provide recommendations along with target share price. 13 analysts offering 12-month price forecasts for Recursion Pharmaceuticals-a (RXRX) have a share price target of $9. This median of share price forecast represents a 39.1% upside from the latest price of $6.47 as on 06.03.25.
Recursion Pharmaceuticals-a (RXRX) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Recursion Pharmaceuticals-a (RXRX) share price will touch around $9 in next 12-months.
Recursion Pharmaceuticals-a (RXRX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Recursion Pharmaceuticals-a's share price and its median forecast price. As on 06.03.25, the difference is -35.07%
Recursion Pharmaceuticals-a (RXRX): Difference between Current Price & Median Forecasted Price
Recursion Pharmaceuticals-a (RXRX) Share Price : Analyst Recommendation
Based on 13 analysts tracking and researching Recursion Pharmaceuticals-a (RXRX) share have hold recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 5 | 5 | 5 |
| Outperform | 2 | 2 | 2 |
| Hold | 6 | 6 | 6 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |